Barclays PLC Ironwood Pharmaceuticals Inc Put Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 15, 2024	BUY	$8.79 - $11.51 $1.77 Million - $2.32 Million	201,400 Added 137.38%	348,000 $3.98 Million
Q3 2023 Nov 07, 2023	BUY	$8.25 - $11.35 $1.21 Million - $1.66 Million	146,600 New	146,600 $1.41 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $7,800 - $16,129	-1,000 Reduced 1.96%	50,000 $518,000
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $715,500 - $882,499	50,000 Added 5000.0%	51,000 $941,000
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $4.72 Million - $6.46 Million	-399,000 Reduced 99.75%	1,000 $19,000
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $4.86 Million - $5.83 Million	400,000	400,000 $6 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.